Guidance

Release of veterinary medicinal products to the market (VMGN 18)

Veterinary medicines guidance note for holders of marketing authorisations (MAs) and autogenous vaccine authorisations (AVAs) on batch release schemes.

From:
Veterinary Medicines Directorate
Published
31 July 2013

This publication was withdrawn on

Replaced by Apply to release a batch of immunological veterinary medicine onto the UK market and Apply to release a batch of pharmaceutical veterinary medicine onto the UK market

Documents

Release of Veterinary Medicinal Products to the UK Market

Ref: VMGN No. 18

PDF, 456 KB, 16 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email postmaster@vmd.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

The batch release scheme relates to authorised Immunological Veterinary Medicinal Products (IVMPs) which cannot be placed onto the UK market without a batch release request submitted to the Veterinary Medicines Directorate (VMD).

The specific batch control scheme relates to authorised veterinary pharmaceuticals, which can be released onto the market without the requirement to inform the VMD if there is an MA for the medicine.

Published 31 July 2013

Related content